Analysis: Euro and emerging economies and equities switch tracks
LONDON (Reuters) – Western European economies are spluttering to life again at last just as emerging markets cool down – confirming one of the investment themes of 2013 and questioning how much financial markets have already discounted these inflection…
Glencore, JPM sued in U.S. as warehousing legal battle ramps up
SINGAPORE (Reuters) – Glencore Xstrata and JPMorgan Chase & Co face a U.S. lawsuit, along with the London Metal Exchange, alleging they artificially inflated aluminum prices, in the second legal challenge related to metal warehousing in a week.
BHP CEO says taking long view on potash
MELBOURNE (Reuters) – BHP Billiton’s new boss on Wednesday shrugged off Russian potash producer Uralkali’s exit from one of the world’s two big potash cartels, saying BHP was taking a long-term view on its planned entry into the industry.
Glenview rejects HMA offer, demands board overhaul
(Reuters) – Glenview Capital Partners rejected hospital operator Health Management Associates Inc’s offer to add a few of the hedge fund’s nominees to its board, reiterating its demand for a complete overhaul of the board.
Fonterra CEO: Future of my tenure up to company’s board
WELLINGTON (Reuters) – Fonterra Chief Executive Officer Theo Spierings said the future of his tenure at the company following a global food safety scare is up the board of the world’s largest dairy exporter.
China says fined milk powder companies ‘disrupted market order’
BEIJING (Reuters) – Six milk powder companies fined for price fixing in China set restrictions on minimum prices and used a variety of methods to “disrupt market order” and restrict competition, China’s top economic planning body said on Wednesday.
Wal-Mart weighs bid for Li’s Hong Kong supermarket chain: sources
HONG KONG (Reuters) – Wal-Mart Stores Inc is considering making a bid for the Hong Kong supermarket business being sold by a company controlled by Asia’s richest man Li Ka-shing, people familiar with the matter told Reuters.
Abbott agrees to pay $12 million fine in China price fixing probe
SHANGHAI (Reuters) – Abbott Laboratories has agreed to pay a fine amounting to around $12 million, a spokeswoman said in emailed comments on Wednesday, following Chinese investigations into price fixing and anti-competitive practices by foreign baby fo…
SEC not to move against hedge fund Magnetar over mortgages: WSJ
(Reuters) – The U.S. securities regulator has decided not to file civil charges against hedge fund firm Magnetar Capital LLC over its role in helping create mortgage securities that lost value during the financial crisis, the Wall Street Journal report…
China fines six companies for price fixing: Xinhua
BEIJING (Reuters) – China’s economic planner hit six companies with a total of 670 million yuan ($109.5 million) in fines for price fixing, state media said on Wednesday.
